文献速递免疫规划传染病防控与疫情报告

G2P[4]株演化动态与轮状病毒疫苗接种:Rotarix证据综述

Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.
PubMed 文献 · Vaccine · 2020-07-07

本文综述轮状病毒疫苗大规模接种背景下基因型演化,重点分析G2P[4]株相对流行率暂时升高的现象。接种Rotarix、RotaTeq或混合程序的国家间G2P[4]流行率年度波动无实质差异,Rotarix对包括G2P[4]在内的非疫苗株所致胃肠炎显示有效。基因型分布变化可能为病毒演化固有过程,无证据表明出现疫苗逃逸株暴发。

要点

  • G2P[4]流行率年度波动呈自然发生,不同疫苗程序国家间无实质差异。
  • Rotarix对非疫苗株(含G2P[4])所致胃肠炎显示有效性和效果。
  • 基因型分布变化可能为病毒演化固有过程,需持续监测但勿误归因于疫苗。

核心结论

  • 轮状病毒基因型分布变化很可能是病毒演化以适应感染人肠道的固有过程,大规模接种后胃肠炎发病率大幅下降且该态势可能维持。
  • 目前无确凿证据表明全球轮状病毒疫苗使用以来出现新株或疫苗逃逸株的异常暴发。

研究设计与样本

  • 本文为综合性文献综述,旨在提供大规模接种Rotarix背景下轮状病毒基因型演化(尤其G2P[4])的见解。

主要发现

  • 接种后时代菌株监测数据显示,实施与未实施轮状病毒疫苗接种规划的国家均出现时间和空间上的变化。
  • G2P[4]流行率的年度波动似乎自然发生,使用Rotarix、RotaTeq或混合接种程序的国家间无实质差异。
  • Rotarix对非疫苗株(包括G2P[4])所致胃肠炎显示有效性和效果。
  • 全球轮状病毒疫苗使用以来,无确凿证据表明出现新株或疫苗逃逸株的异常暴发。

临床怎么用

  • 鉴于轮状病毒株随时间自然波动,解读菌株动态的时间变化时应谨慎,避免误归因于疫苗接种。
  • 对可能增加当前轮状病毒疾病负担的菌株出现应持续监测,并需通过全基因组测序等彻底表征才能确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rotavirus (RV) gastroenteritis is a vaccine-preventable disease that creates high medical and economic burden in both developed and developing countries. Worldwide, more than 100 countries have introduced RV vaccines in their national immunization programs, and the remarkable impact of reducing the burden of severe childhood gastroenteritis has been unequivocally demonstrated. Currently, 2 oral vaccines (Rotarix, GSK and RotaTeq, Merck) are widely utilized. Recent temporary increases in the relative prevalence of G2P[4] RV strains have been observed in countries implementing RV vaccination. This comprehensive literature review aims to provide an insight on RV genotype evolution in the context of mass vaccination with Rotarix, particularly in the case of G2P[4]. In the post-vaccine era, strain surveillance data indicated temporal and spatial changes in countries both with and without RV vaccination programs. Annual fluctuations in G2P[4] prevalence seem to occur naturally, with no substantial differences between countries using Rotarix, RotaTeq or mixed vaccination programs. Moreover, Rotarix has been shown to be efficacious and effective against gastroenteritis caused by non-vaccine strains, including G2P[4]. These data indicate that shifts in RV genotype distribution are likely to constitute an inherent process of virus evolution to infect the human gut. Following RV vaccine introduction, incidences of RV gastroenteritis declined dramatically and mass vaccination will likely maintain this status, despite possible fluctuations in the relative distribution of genotypes. There is no conclusive evidence of unusual burst of new or vaccine-escape strains since global RV vaccines use. The emergence of strains with a potential to increase the current burden of RV disease should be continuously monitored and can only be established by exhaustive characterization of strains, including whole genomic sequencing. Given the natural fluctuations in RV strains over time, caution is advised when interpreting temporal changes in RV strain dynamics, as they could mistakenly be attributed to vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bibera GL, Chen J, Pereira P, et al. Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix. Vaccine. 2020. PMID: 32651115. doi:10.1016/j.vaccine.2020.06.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。